The Deal Register
Database › Equity financing › Innocan Pharma Announces Offering of a Debenture to its Largest…

Equity financing

Innocan Pharma Announces Offering of a Debenture to its Largest Shareholder, Tamar Innovest

Lane
Equity financing
Announced
11 Mar 2026
Province
Alberta
Industry
Healthcare & life sciences
Status
Announced
What the filing says
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the " Company " or " Innocan ") is pleased to announce that it intends to complete an offering of a debenture of the Company (the " Debenture ") to its largest shareholder, Tamar Innovest Ltd. (" Tamar Innovest ") for gross proceeds of US $450,000 (the " Offering ").
Terms stated
interest rate
Source

The terms are in the subscriber edition

This transaction carries 1 stated term, with its value, unit and basis and the consideration.

Subscribe

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe